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The transformation of ginsenoside Rb1 into a speciﬁc minor ginsenoside using Aspergillus niger KCCM
11239, as well as the identiﬁcation of the transformed products and the pathway via thin layer chro-
matography and high performance liquid chromatography were evaluated to develop a new biologically
active material. The conversion of ginsenoside Rb1 generated Rd, Rg3, Rh2, and compound K although
the reaction rates were low due to the low concentration. In enzymatic conversion, all of the ginsenoside
Rb1 was converted to ginsenoside Rd and ginsenoside Rg3 after 24 h of incubation. The crude enzyme
(b-glucosidase) from A. niger KCCM 11239 hydrolyzed the b-(1/6)-glucosidic linkage at the C-20 of
ginsenoside Rb1 to generate ginsenoside Rd and ginsenoside Rg3. Our experimental demonstration
showing that A. niger KCCM 11239 produces the ginsenoside-hydrolyzing b-glucosidase reﬂects the
feasibility of developing a speciﬁc bioconversion process to obtain active minor ginsenosides.
opyright  2013, The Korean Society of Ginseng, Published by Elsevier. Open access under CC BY-NC-ND license. 1. Introduction
Ginseng, the root of Panax ginseng Meyer, is one of the most
popular traditional herbal medicines. It has been used for thou-
sands of years in Asian countries, and has also recently become
popular in Western countries. Ginseng harbors a variety of bioac-
tive compounds, including ginsenosides (ginseng saponins),
acidic polysaccharides, phenolics, and polyacetylenes [1]. Among
these, the ginsenosides have been well characterized for their
functionality, and are thus regarded as the principal components
responsible for the pharmacological and biological activities of
ginseng [2].
Ginsenosides are composed of a dammarane backbone with
several side chains, including glucose, arabinose, xylose, and
rhamnose side chains [3]. Thus far, more than 50 types of ginse-
nosides have been isolated and identiﬁed from Panax ginseng
Meyer [4]. Based on the differences in their chemical constitutions,
the ginsenosides are generally classiﬁed into three types: proto-
panaxadiol (PPD), protopanaxatriol, and olenolic acid. Among those
thus far identiﬁed, six major ginsenosides (Rb1, Rb2, Rc, Rd, Re, and
Rg1) have been determined to account for 90% of the total ginse-
noside content of P. ginseng Meyer [5]. In particular, ginsenosideence, Konkuk University, Seoul 143
inseng, Published by Elsevier. OpeRb1 is present in greater abundance (usually >20% of total ginse-
nosides) than any other ginsenosides in P. ginseng, Panax quinque-
folius, Panax japonicum and Panax notoginseng [6]. Earlier reports
have shown that the major PPD-type ginsenosides (Rb1, Rb2, Rc,
Rd) are metabolized by intestinal bacteria after oral administration
to minor ginsenosides such as Rg3, Rh2, F2, and compound K (CK)
[7]. In recent years, it has been demonstrated that the minor gin-
senosides possess remarkable pharmaceutical activity and can be
readily absorbed by the human body [8]. For example, ginsenoside
Rg3 induces tumor cell apoptosis, inhibits tumor cell proliferation
and attenuates tumor invasion and metastasis [9,10]. In addition,
Rg3 serves as a natural cytoprotective agent against environmental
carcinogens [11]. Therefore, a variety of studies have focused on the
conversion of major ginsenosides to the more active minor ginse-
nosides via methods such as heating [12], acid treatment [13], alkali
treatment [14], and enzymatic conversion [15,16]. Chemical trans-
formation induces side reactions including epimerization, hydrox-
ylation, and hydration, and also generates more environmental
pollution [17]. By contrast, microbial or enzymatic approaches have
arisen as the predominant conversion modalities, owing to their
marked selectivity, mild reaction conditions, and environmental
compatibility.-701, Korea.
n access under CC BY-NC-ND license. 
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enzymes that can transform Rb1 into minor ginsenosides such as Rd,
F2, Rg3, and compound K [4,17e20]. However, the majority of the
microorganismsemployed in theseexperimentsarenotof food-grade.
Aspergillus niger strain has been known to be one of the most
popular fungi in fermentation of the crops such as soybean and in
brewing industry due to its production of various hydrolyzing
exoenzymes [21]. In particular, production of glucosidase by using
A. niger as a good producer has been recently studied by many
researchers [22]. Therefore, in this study, we focused narrowly on
the transformation of ginsenoside Rb1 into speciﬁc minor ginse-
nosides using A. niger, which has been generally regarded as safe by
the Food and Drug Administration.
2. Materials and methods
2.1. Materials
Ginsenosides Rb1, Rd, 20(S)-Rg3, 20(R)-Rg3, Rh2, and CK were
purchased from Vitrosys, Inc. (Yeongju, Korea). Ginsenoside Rb1,
Rd, 20(S)-Rg3, and 20(R)-Rg3. r-Nitrophenyl-b-D-glucopyranoside
(PNPG), r-nitrophenol (PNP), and b-glucosidase from almond were
purchased from Sigma-Aldrich (St Louis, MO, USA). Potato dextrose
broth was purchased from Difco (Miller, Becton Dickinson, and Co.,
Sparks, MD, USA). Celluclast 1.5L and Cellulase 12T were purchased
from Novozymes (Bagsværd, Denmark) and Bioland Co. (Chung-
nam, Korea), respectively. High performance liquid chromatog-
raphy (HPLC; Agilent 1100 series; Agilent Technologies, Palo Alto,
CA, USA) was conducted using a UV/vis detector and a gradient
pump. All solvents used in chromatographywere of HPLC grade and
all other chemicals were of analytical reagent grade.
2.2. Growth and crude enzyme production
A. niger KCCM 11239 was purchased from the Korean Culture
Center of Microorganisms (KCCM, Seoul, Korea). The fungus was
cultured on potato dextrose agar at 30C for 4 d, and the stock
cultures were maintained at 4C. Erlenmeyer ﬂasks were ﬁlled to
20% of their volume with potato dextrose broth, and subsequently
inoculated with 5-d cultures. The cultures were grown for 16 d
under shaking conditions at 200 rpm at 30C. During the shake
ﬂask culturing, a few glass beads were added to prevent mycelial
clumping and thus to achieve homogeneous growth. After incu-
bation, the culture broth was centrifuged at 9,000  g at 4C for
10min, and a crude enzymewas obtained by precipitationwith 70%
of (NH4)2SO4 of the supernatant. The speciﬁc activity of crude
enzyme was detected to 91 U/mg.
2.3. Assay of enzyme activity
Beta-glucosidase activity was evaluated via a colorimetric
method using PNPG as a substrate. The reaction mixture, which
contained 1 mL of 5 mM PNPG and 100 mL of enzyme solution, was
incubated at 50C for 10 min. The reaction was subsequently
terminated via the addition of 1 mL of 0.5 M NaOH, and the ab-
sorption of the released PNPwasmeasured at 400 nm. One unit of b-
glucosidase activity was deﬁned as the quantity of enzyme required
to liberate 1 mM of PNP/min under standard conditions [23].
2.4. Biotransformation of ginsenoside Rb1
Microbial transformation was conducted via a modiﬁed Cheng’s
method [24]. In brief, suspensions of the 5 d-old cultures were
mixed with an equal volume of 1 mM ginsenoside Rb1 dissolved in
0.5 M sodium phosphate buffer (pH 5.5) and were shaken for 16 d,200 rpm, at 30C. Enzymatic transformation was conducted with
200 mL of a 16-d culture supernatant (centrifuged at 14,400  g for
30 min at 4C) and the same volume of 1 mM ginsenoside Rb1 was
reacted for 48 h at 30C and 50C. Aliquots were withdrawn at
suitable time intervals (0.5 h, 1 h, 2 h, 4 h, 8 h, 12 h, and 24 h). To
compare of ginsenosides produced by commercial b-glucosidase, a
200 mL of each enzyme solution (approximately 200 U) was added
into a reaction mixture and samples were picked for thin layer
chromatography (TLC) after 48 h.
2.5. Extraction of crude saponin
The reaction mixtures were extracted twice with 200 mL of
water-saturated n-butanol. The n-butanol fraction was evaporated
to generate the crude saponin fraction with a rotary vacuum
evaporator (N-1000V, EYELA, Tokyo, Japan). Crude saponin was
dissolved in 50 mL of methanol, which was subjected to TLC and
HPLC determination. The samples were then passed through a
0.45 mm PTFE syringe ﬁlter (Whatman, Brentford, Middlesex, UK)
prior to injection.
2.6. TLC and HPLC analysis for determination of ginsenosides
TLC was conducted on silica gel 60F254 plates. A solvent mixture
of chloroform:methanol:water (65:35:10 v/v/v, lower phase) was
used as the developing solvent. The spots were detected by
spraying with 10% sulfuric acid followed by heating under a lamp
ﬂame until the spots became clearly visible. Ginsenosides and
transformed ginsenosides were identiﬁed and assayed via com-
parison with known ginsenoside standards.
HPLC was conducted using an Agilent 1100 system (Agilent
Technologies) at a detection wavelength of 203 nm. The column
used was a reverse-phase column (C18, 4.6 mm  150 mm, 5 mm)
and an injection volume of sample was 20 mL. The mobile phase
utilized gradient conditions with solvents A (CH3CN:H2O ¼ 100:0)
and B (CH3CN:H2O ¼ 14:86). The solvent A and B ratios were as
follows: [20% A (0 min)]; 20% A (5 min); 30% A (10 min); 30% A
(15 min); 60% A (20 min); 60% A (23 min); 0% A (25 min)] with a
1.2 mL/min ﬂow rate.
2.7. Statistical analysis
Each experiment was individually repeated three times. All data
were assigned for purposes of comparison and an analysis of
variance (ANOVA) was carried out by using SPSS version 8.0 (SPSS
Inc., Chicago, IL, USA). A p-value of <0.05 was considered
signiﬁcant.
3. Results
3.1. Microbial conversion of ginsenoside Rb1 during culturing
Aspergillus species are known as a useful source of b-glucosidase
and A. niger is by far the most efﬁcient b-glucosidase producer
among the microorganisms investigated thus far. Changes in the
growth and b-glucosidase activity of A. niger KCCM 11239 on potato
dextrose broth medium at 30C were evaluated under aerobic
conditions (data not shown). Very little b-glucosidase was detected
in the culture broth until 12 d, but then the activity dramatically
increased and reached to a maximum level (197.7 U/mL) after
approximately 16 d. After that time, it appeared that the activity
was slightly decreased by protease existing in culture broth. From
the results, it is presumed that a production pattern of b-glucosi-
dase is nongrowth associated type.
Fig. 1. TLC analysis of the time-course transformation of ginsenoside Rb1 by Aspergillus
niger KCCM 11239. Suspensions of the 5-d cultures were mixed with an equal volume
of 1 mM ginsenoside Rb1. S is the mixture of ginsenoside standards; TLC, thin layer
chromatography.
K.H. Chang et al / Ginsenoside conversion by fungi glucosidase 49The microbial conversion of ginsenoside Rb1 was prepared by
inoculating ginsenoside Rb1 into precultured suspensions, fol-
lowed by 16 d of incubation of the mixture at 30C and 200 rpm.
The microbial conversion was checked via TLC at 2-d intervals.
During the 2-d growth period, much of the enzyme seemed to be
produced, as evidenced by the observation of increased ginseno-
side Rg3 levels. Fig. 1 shows that most of the ginsenoside Rb1 was
converted to ginsenoside Rg3 and generated less polar metabolites
after 4 d of incubation. Indeed, after 10 d, A. niger produced a less
polar metabolite, with an Rf value similar to that of ginsenoside Rh2
and compound K. This result suggests that themicrobial conversion
of ginsenoside Rb1 using A. niger KCCM 11239 induced the pro-
duction of diverse PPD-type ginsenosides. We estimated that this
result was induced by different types of b-glucosidase from A. niger
KCCM 11239.
Aspergillus species are known to produce different types of b-
glucosidase. For example, Aspergillus sp. g48p produces two types
of ginsenoside-hydrolyzing b-glucosidases: ginsenosidase type IIFig. 2. TLC analysis of time-course transformation of ginsenoside Rb1 by the crude enzyme
1 mM ginsenoside Rb1 and then reacted for 24 h at (A) 30C and (B) 50C. S is the mixturhydrolyzes 20-O-glycosides of PPD-type ginsenosides and ginse-
nosidase type I hydrolyzes 3-O and 20-O glycosides of PPD-type
ginsenosides [25].
3.2. Enzymatic conversion of ginsenoside Rb1
The enzymatic conversion of ginsenoside Rb1 over a time-
course was conducted using a crude enzyme. Ginsenoside Rb1 was
reactedwith the same volume of crude enzyme for 48 h at 30C and
50C; the TLC results are shown in Fig. 2. When ginsenoside Rb1
was reacted at 30C, the levels of ginsenoside Rd were increased
within 30 min and the levels of ginsenoside Rg3 were increased
after 4 h. All of the ginsenoside Rb1 was converted to ginsenoside
Rd and ginsenoside Rg3 after 24 h of incubation. Ginsenoside Rb1
was reacted with crude enzyme at 50C to compare the effects of
the reaction temperature. The results demonstrate that high reac-
tion temperatures accelerate the reaction to produce ginsenoside
Rg3. In addition, the conversion activity of A. niger after 48 h of a
reaction time were compared by using three commercial enzymes
(Fig. 3). When ginsenoside Rb1 was reacted with Celluclast 1.5L and
Cellulase 12T, the content of ginsenoside Rb1 was reduced and a
productivity of Rd increased after 48 h. However, these enzymes
were not converted further into active minor ginsenosides Rg3. In
case of b-glucosidase from almond, ginsenoside hydrolyzing ac-
tivity was not detected.
3.3. HPLC assay of metabolites
Various products of Rb1 transformed by the crude enzyme
isolated from A. niger KCCM 11239 were conﬁrmed via HPLC anal-
ysis. The proﬁle of the reaction mixture of ginsenoside Rb1 at 30C
for 24 h of reaction is shown in Fig. 4. HPLC analysis yielded results
similar to the ﬁndings of TLC. In addition, the amount of ginseno-
side Rb1 was reduced with the extension of the reaction time,
whereas other hydrolysis products including ginsenoside Rd and S-
Rg3 increased after 24 h of incubation at 30C. Ginsenoside Rb1
harbors four b-glucosidic linkages, including a 20-C, b-(1/6) and a
3-C, b-(1/2) linkage. Fig. 4 shows that a peak area of Rd in a
sample increased after 8 h, but decreased after 24 h. In the mean-
time, ginsenoside Rg3 was detected in a 24 h-reaction mixture and
a ratio of the peak area was approximately 48.5%. By contrast,
ginsenoside Rb1was not detected in a 24-h reaction mixture. Thesefrom Aspergillus niger KCCM 11239. Crude enzyme was mixed with an equal volume of
e of ginsenoside standards; TLC, thin layer chromatography.
Fig. 3. Comparison of ginsenoside Rb1 transformation activity using commercial en-
zymes. S, ginsenoside standards; 1, crude enzyme from Aspergillus niger KCCM 11239;
2, Celluclast 1.5L; 3, Cellulase 12-T; 4, b-glucosidase from almond.
J Ginseng Res 2014;38:47e5150results show that ginsenoside Rb1 can be converted to ginsenoside
Rd by the loss of a glucosemoiety at the b-(1/6)-glucosidic linkage
of the C-20 position of the ginsenoside aglycon [26]. Finally, gin-
senoside Rg3 can also be produced from ginsenoside Rd via the
additional hydrolysis of a glucose moiety. In production of ginse-
noside Rg3, a peak area ratio of ginsenoside 20(S)-Rg3:20(R)-Rg3
isomer was calculated to be approximately 83:17. There have beenFig. 4. Time-course HPLC analysis of metabolites of ginsenoside Rb1 converted by the crude
volume of 1 mM ginsenoside Rb1 and reacted for 24 h at 30C. HPLC, high performance liqprevious reports on microbial sources capable of converting the
major ginsenoside Rb1 to ginsenoside Rg3. Microbacterium sp.
GS514 exhibited a marked ability to convert ginsenoside Rb1 to Rg3
[4]. The enzymes isolated from the strain GS514 hydrolyzed the
terminal glucose and then the inner glucose at position C-20.
Ginsenosidase type II from Aspergillus sp. g48p hydrolyzed PPD
ginsenosides such as Rb1, Rb2, Rc, or Rb3 to generate Rd, and also
slowly hydrolyzes the 20-O-glucoside of Rd to produce a very small
quantity of ginsenoside Rg3 [25].
It was reported that ginsenoside Rd as an intermediate has a
variety of pharmaceutical activities, including the prevention of
kidney injury by chemical drugs [27], the prevention of the con-
centration of blood vessels [28], enhancement of the differentiation
of neural stem cells [29]. In addition, it has been shown that gin-
senoside Rg3, in particular the S form Rg3, prevents endothelial cell
apoptosis via the Akt-dependent inhibition of the mitochondria
[10], and regulates voltage-dependent Ca2þ, Naþ, and Kþ channel
activity [30].
In conclusion, it has been shown that ginseng has various bio-
functional effects including ginsenosides and their derivatives.
Ginsenoside Rb1 is present in greater abundance than any other
ginsenosides in the root, but ginsenoside Rg3 has greater biological
effects for human health though its content is relatively very low in
ginseng. We can transform from Rb1 to Rg3 by using enzymatic
hydrolysis for a larger production. The pathway of enzymatic hy-
drolysis of Rb1 to produce Rb3 has already been shown by Chang
et al [31]. A production yield of minor ginsenoside such as Rg3
depends on many kinds of glucosidase. In this study, hydrolysis of
Rb1 by b-glucosidase produced from the A. niger strain was eval-
uated comparingwith a commercial enzyme such as Celluclast 1.5L,
Cellulase 12T, and other b-glucosidase (from almond) for higherenzyme from Aspergillus niger KCCM 11239. The crude enzyme was mixed with an equal
uid chromatography; S is the mixture of ginsenoside standards.
K.H. Chang et al / Ginsenoside conversion by fungi glucosidase 51yields of Rg3. From these results, it appeared that b-glucosidase
produced from A. niger strain had a greater hydrolytic activity on
Rb1 than any other glucosidase tested in this study. Actually, a
crude enzyme of this study has various glucosidase [25], and it is
thought that hydrolysis of Rb1 is done by a combination of these
glucosidases. As further research, we will examine the mechanism
of hydrolysis with combined enzymes of crude samples. These
compounds can be used for the development of new pharmaceu-
tical materials such as antiturmeric agents and this is a valuable
technique for bioconversion for new compounds in the pharma-
ceutical industry.
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